Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.
As the senior director of research for Kaiser Permanente in Southern California, Steven Jacobsen, MD, PhD, leads dedicated scientists and clinicians who use information collected during doctor and hospital visits to determine what really works — and what doesn’t work — in health care.
Stephen Parodi, MD, associate executive director, The Permanente Medical Group, and executive vice president, The Permanente Federation, recently highlighted the value of Kaiser Permanente’s integrated care system for cancer patients as part of the Self-Insurance Institute of America’s 39th annual Nation Educational Conference & Expo in San Francisco.
A Kaiser Permanente study finds 10-year follow-up interval after negative colonoscopies is associated with reduced risk of colorectal cancer and mortality.
Permanente physicians and radiologists in Northern California created and validated a novel process for categorizing the risks from ovarian masses.
Five of the organization’s research centers received grants to conduct research to improve cancer screening, focusing on lung, cervical, and colorectal cancer.